SureTrader
Interactive Brokers Advertisement
SureTrader
Home > Boards > US OTC > Biotechs >

Immune Therapeutics Inc. (IMUN)

IMUN RSS Feed
Add IMUN Price Alert      Hide Sticky   Hide Intro
Moderator: crudeoil24, The Rainmaker, JDoggs_Money, dwarren428
Search This Board: 
Last Post: 6/21/2017 7:14:20 AM - Followers: 76 - Board type: Free - Posts Today: 0

The following Powerpoint is copy and pasted from the June 12th 8-k...

https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12122447


















3 great videos to watch on Low Dose Naltrexone 

https://www.youtube.com/watch?v=YtDxpA52NvU (4 mins, very uplifting encouraging video about a woman's story on LDN) 

https://www.youtube.com/watch?v=FDCn0JWv6Io (59 mins; very informative documentary telling the story of LDN) 

https://www.youtube.com/watch?v=rll1A3aFhjc (79 mins; "[the late] Dr Bihari [the pioneer of low dose naltrexone] is Interviewed about Low Dose Naltrexone LDN for Normalizing Immune System Function") 


2 great books on Low Dose Naltrexone 

https://www.amazon.com/Promise-Low-Dose-Naltrexone-Therapy/dp/0786437154/ref=sr_1_2?ie=UTF8&qid=1497648079&sr=8-2&keywords=low+dose+naltrexone 

https://www.amazon.com/LDN-Book-Little-Known-Naltrexone-Revolutionize/dp/1603586644/ref=pd_bxgy_14_img_2?_encoding=UTF8&pd_rd_i=1603586644&pd_rd_r=GPZPCV3F5HAS56V1CT2F&pd_rd_w=NLw9g&pd_rd_wg=ExBQX&psc=1&refRID=GPZPCV3F5HAS56V1CT2F
 


Other Important Links:

8-k from 4/27/16: LDN is approved in Nigeria

8-k from 5/23/17: LDN gets marketing approval in Nigeria

8-k from 4/13/17: Debt restructuring to eliminate a very "toxic" note. This 8-k may have marked the inflection point on the graph of IMUN

Letter of Intent from Fidson Healthcare PLC - this was a publishing from August 2015 that popped IMUN to just over $0.30 briefly

The medicine your doctor never told you about (but should have)

Stock Quote of Fidson Healthcare PLC - IMUN's partner for marketing / distribution in Nigeria - notice how the ticker has shot up since April on NO PUBLISHED NEWS

www.lowdosenaltrexone.org

Low-Dose Naltrexone (LDN): One of the RARE Drugs that Actually Helps Your Body to Heal Itself

My experience with Low Dose Naltrexone By David Gluck, MD (the story of a lifelong friend of Dr. Bernard Bihari, the pioneer of LDN)

11 Facts about HIV in Africa

We now have a NEW Senior Regulatory Advisor (see last page of powerpoint) who is ALSO the Senior Regulatory Officer for the GATES FOUNDATION!


Contact Info

  • 37 North Orange Ave
    Suite 607
    Orlando, FL 32801
       
  Authorized Shares 500,000,000 a/o May 31, 2017
  Outstanding Shares 313,406,831 a/o May 31, 2017
 

 

 

Patent and Subsidiary Acquisition

The Company entered into a share exchange agreement on April 24, 2012 to acquire all of the outstanding shares of TNI BioTech IP, Inc. (“TNI IP”), a biotechnology firm incorporated in Florida and formed to acquire patents related to the treatment of cancer and HIV/AIDS and autoimmune diseases, using Met-enkephalin (“MENK”) and Naltrexone (“LDN”). The goal of TNI IP’s management was to enable mankind and civilization to combat fatal diseases by activating and mobilizing the body’s own immune system using TNI IP’s patented use of MENK. The first patents acquired by TNI IP were acquired from Dr. Nicholas P. Plotnikoff and Professor Fengping Shan in 2012. TNI IP was acquired in exchange for 20,250,000 shares of the Company’s common stock, of which 8,000,000 shares were issued to Dr. Plotnikoff for the acquisition of patents and the remaining 12,250,000 shares were issued to the founders of TNI IP in exchange for all of their right, title and interest in their TNI IP shares. The goodwill arising on the acquisition of TNI BioTech IP, Inc. was valued at $98,000,000 and license agreements arising from the acquisition of TNI IP were valued at $16,006,000.

  • Cytocom. Cytocom Inc. is our affiliate clinical-stage pharmaceutical company focused on advancing IRT-103 (US FDA designator for ‘Lodonal’). It is responsible for the development of our patented therapies with the FDA and EMA. It will lead the US and EMA (“European Medical Association”) clinical trials on IRT-103 including for Crohn’s disease. We have quietly made solid progress advancing Cytocom toward our next major goal, which is to finance it as a standalone entity, possibly publicly traded depending on its capital market valuation and profile.

    The following link contains an important Powerpoint presentation. Page 8 of the presentation is a key page. As of March 31, 2017, IMUN owns a 13.3% stake in Cytocom, which has been diluted down from an original 55% stake when the spinoff occured in 2014. 
    http://www.cytocom.com/investors/
  • Advance IMUN’s Growing Drug Pipeline. We have started our second clinical for Lodonal as an adjunct treatment for cancer in Malawi, which is slated for completion in mid-2017, with results to be published in the second half of the year. We also plan a bridging trial with MENK for cancer in Nigeria, capitalizing on our strong relationship with NAFDAC -– amongst other clinical trials being developed or planned.

    Increase the IP Portfolio. We will continue to protect the value of our clinical research by building intellectual property value as an asset, thus erecting barriers to entry. We filed two new patents surrounding Lodonal in 2016.
     
    Establish a Solid Base of Operations in China. Our Chief Science Officer and Vice Director of the Institute of Immunology, China Medical University in Shenyang, China have been treating patients with MENK and our new cocktail therapy throughout 2016 with positive results. Now that our patents are filed for the cocktail, we plan to publish results in 2017 as part of a larger initiative to advance clinical trials, and establish a solid beachhead in this nation of 1.4 billion people as a gateway to Asia.  Our goal is to open our cancer clinic in China to treat patients by year-end 2017.
     
    Reinforce the IMUN Management Team and Boards. As we grow, and our opportunities increase, we plan to add highly accomplished executives to our management team and boards from the fields of science, medicine, pharmaceuticals and finance to help drive the Company’s growth.






 
IMUN
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
IMUN News: Current Report Filing (8-k) 06/12/2017 06:04:21 AM
IMUN News: Current Report Filing (8-k) 05/23/2017 11:12:57 AM
IMUN News: Quarterly Report (10-q) 05/12/2017 12:32:57 PM
IMUN News: Current Report Filing (8-k) 05/09/2017 06:09:05 AM
IMUN News: Current Report Filing (8-k) 04/28/2017 03:57:12 PM
PostSubject
#3035  Sticky Note I mentioned this earlier in the week, but dwarren428 06/16/17 10:16:00 AM
#2953  Sticky Note Gates Foundation money is a big deal here. crudeoil24 06/09/17 09:01:10 AM
#2366  Sticky Note IMUN: The CEO gave Lodonol contract numbers during The Rainmaker 04/15/17 02:01:35 PM
#2316  Sticky Note Here’s my DD for $IMUN: JDoggs_Money 04/13/17 10:26:58 PM
#3051   This is a game of patience! I don't tjguy 06/21/17 07:14:20 AM
#3050   Actually, better yet just email Noreen, and tell dwarren428 06/20/17 02:53:58 PM
#3049   Call IRP and tell them what you just dwarren428 06/20/17 02:50:46 PM
#3048   She said sales would commence immediately upon approval, The Rainmaker 06/20/17 02:48:57 PM
#3047   It was "reaching 25,000 patients in the first dwarren428 06/20/17 02:47:32 PM
#3046   In the CC The contract she said she The Rainmaker 06/20/17 02:26:37 PM
#3045   "CC sure made it seem like it would dwarren428 06/20/17 02:19:31 PM
#3044   CC sure made it seem like it would The Rainmaker 06/20/17 02:16:26 PM
#3043   Ain't nothing happening here until we get initial dwarren428 06/20/17 01:31:36 PM
#3042   Of course we've all heard this one before, dwarren428 06/18/17 11:24:45 AM
#3041   Nevermind, I just put it in the Ibox. dwarren428 06/17/17 01:46:03 AM
#3040   A few weeks ago, I sent one of dwarren428 06/16/17 05:33:48 PM
#3039   mean weimaraner, can you sticky this post? dwarren428 06/16/17 05:24:30 PM
#3038   I like the support we're getting around .05. dwarren428 06/16/17 05:04:15 PM
#3037   I added a little more today and have Lapbid 06/16/17 11:57:44 AM
#3036   If Gates Foundation is involved with funding initial Herold 06/16/17 11:28:56 AM
#3035   I mentioned this earlier in the week, but dwarren428 06/16/17 10:16:00 AM
#3034   Who would have ever guessed that after all tjguy 06/15/17 09:52:42 AM
#3033   Got it. tjguy 06/15/17 12:16:26 AM
#3032   I didn't say I called the transfer agent. dwarren428 06/14/17 11:14:46 PM
#3031   And didn't you call the TA and get tjguy 06/14/17 06:55:32 PM
#3030   Fidson Healthcare Plc (IMUN's partner in Nigeria) stock dwarren428 06/14/17 04:37:19 PM
#3029   259.96m is the float dwarren428 06/14/17 02:53:27 PM
#3028   Right, so why did the presentation say 259 dwarren428 06/14/17 02:48:58 PM
#3027   Anyone selling here must be a total moron. Hopeful1037 06/14/17 01:28:53 PM
#3026   How long have the post members. Been w Imun Hopeful1037 06/13/17 08:00:42 PM
#3025   I have been buying more as well. dwarren428 06/13/17 03:17:01 PM
#3024   I keep buying to average down. Been Hopeful1037 06/13/17 03:05:37 PM
#3023   Nobody is buying until we see if Noreen dwarren428 06/13/17 12:03:57 PM
#3021   It doesnt show that. Its useless until they The Rainmaker 06/13/17 11:46:05 AM
#3020   But how does that show. Hopeful1037 06/13/17 11:39:53 AM
#3019   Proof! dwarren428 06/13/17 10:51:57 AM
#3018   I see. Thanks. Makes sense and tjguy 06/13/17 09:38:32 AM
#3017   Nothing from the 8-k or any previous filing dwarren428 06/13/17 08:51:59 AM
#3016   What part of the 8K led you to tjguy 06/13/17 08:15:12 AM
#3015   We're at Post #3000 after 5 years. Give dwarren428 06/12/17 09:39:53 PM
#3014   When contracts are here (if the numbers reflect dwarren428 06/12/17 09:34:48 PM
#3013   We need to get more investors to get Hopeful1037 06/12/17 09:22:35 PM
#3012   Maybe some day Bill Gates will take over dwarren428 06/12/17 08:15:15 PM
#3011   They are downplaying it until the big day. dwarren428 06/12/17 08:10:29 PM
#3010   When are they going to put out press Hopeful1037 06/12/17 06:25:40 PM
#3009   Need numbers in the contracts to really get The Rainmaker 06/12/17 04:13:18 PM
#3008   On May 23rd's 8-k, Noreen is quoted... dwarren428 06/12/17 12:33:20 PM
#3007   Clearly an error. I'm not going to speculate dwarren428 06/12/17 12:25:23 PM
#3006   Right, so why did the presentation say 259 million? tjguy 06/12/17 10:12:23 AM
#3005   That was the best part of the presentation The Rainmaker 06/12/17 10:06:04 AM
#3004   10q said As of May 12, 2017 there The Rainmaker 06/12/17 10:05:31 AM
#3003   It looks like we are waiting for approval tjguy 06/12/17 09:53:06 AM
#3002   And I speculate that Noreen is WAY WAY tjguy 06/12/17 09:47:49 AM
#3001   Gates Foundation monies huge. Associate in 8-k crudeoil24 06/12/17 09:47:34 AM
PostSubject